Article
Rockville, Md. - A three-drug combination for the treatment of melasma is available as a single formula after being used separately since the 1970s.
Post-Hoc Analysis of ALLEGRO-2b/3 Trial Highlights Patient-Reported Outcome Improvements
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
MOPD 2025: Complete Conference Recap
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Reviewing Complex Cases: Special Issues in AD Comorbidities
Expert Insights on Personalizing Atopic Dermatitis Treatment